Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Plenaxis abarelix depot luteinizing hormone releasing hormone/gonadotropin releasing hormone regulatory update

The FDA extended by 90 days its review of PRCS's NDA

Read the full 114 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE